Biological Sciences Division
Published August 14, 2012 | Version v1
Patent Open

Therapeutics to inhibit MLL-menin interaction for treating leukemia

Creators

  • 1. University of Chicago

Contributors

Description

Cell permeable peptides derived from MLL that block the interaction of MLL with menin for the treatment of acute myeloid and acute lymphoid leukemia are disclosed. Small molecules interfere with the interaction of MLL with any of its binding partners.

Files

US8242078.pdf

Files (737.8 kB)

Name Size Download all
md5:a2c3f2b48e7878e43bd74a64a7ac7c99
737.8 kB Preview Download

Additional details

Identifiers

Patent application number
US 44620607 A
Patent number
US 2009/0298772 A1
Other
oai:uchicago.tind.io:8282

Dates

Patent filed
2007-10-19

UChicago Information

Division(s)
Biological Sciences Division
Department(s)
Medicine